A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/713 (2006.01) A61K 31/7105 (2006.01) A61K 31/711 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2556729
The present invention relates to methods of enhancing death receptor-induced apoptosis in MUC1 expressing cells comprising contacting the MUC1 expressing cells with an effective amount of a MUC1 antagonist.
L'invention concerne des procédés de stimulation de l'apoptose déclenchée par le récepteur de mort chez les cellules exprimant le MUC1, qui consistent à mettre en contact les cellules exprimant MUC1 avec une quantité efficace d'un antagoniste de MUC1.
Kharbanda Surender
Kufe Donald W.
Dana-Farber Cancer Institute Inc.
Genzyme Corporation
Kirby Eades Gale Baker
LandOfFree
Muc1 antagonist enhancement of death receptor ligand-induced... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Muc1 antagonist enhancement of death receptor ligand-induced..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Muc1 antagonist enhancement of death receptor ligand-induced... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1803994